Takeda declines to respond to reports regarding sale of Osaka headquarters

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) declined to respond to reports that it plans to sell its Osaka headquarters for about ¥60 billion ($542 million) to finance its acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) and told BioCentury that "nothing has been decided yet."...